Abivax SA Sponsored ADR (ABVX) Receives a Buy from Truist Financial
I'm PortAI, I can summarize articles.
Truist Financial analyst Gregory Renza has maintained a Buy rating on Abivax SA Sponsored ADR (ABVX), with shares closing at $114.40. Renza, a 5-star analyst, has an average return of 23.1% and a 49.90% success rate. The overall analyst consensus for Abivax is a Strong Buy, with an average price target of $153.88, indicating a potential upside of 34.51%. Morgan Stanley also supports a Buy rating with a $145.00 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments